线粒体功能障碍的进展及其在心血管疾病中的作用
Yan Qiu1, Shuo Chang1,2, Ye Zeng3
1Department of Cardiovascular Surgery, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming 650102, China.
Cells
|October 28, 2025
概括
线粒体功能障碍是心血管疾病 (CVD) 的关键,影响能量,压力和质量控制. 准线粒体为心血管疾病管理提供了新的治疗途径.
科学领域:
- 线粒体生物学 线粒体生物学
- 心血管病理生理学
- 翻译医学是一种翻译医学.
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 超出传统风险因素的复杂机制驱动心血管疾病的进展.
- 线粒体功能障碍越来越被认为是心血管疾病发病的一个核心因素.
研究的目的:
- 综合当前关于心血管疾病中线粒体功能障碍的知识.
- 探索线粒体失调和心血管疾病进展之间的联系.
- 评估针对心血管疾病的线粒体向治疗策略.
主要方法:
- 对最近的研究进行了全面的文献综述.
- 专注于线粒体能量代谢,膜潜力和动力学 (融合/裂变,线粒体细胞分裂,生物发生).
- 对药物,基因和再生疗法的批判性评估.
主要成果:
- 线粒体功能障碍有助于内皮功能障碍,心肌损伤和心脏重塑.
- 涉及能量代谢,膜潜力和动态的调节障碍.
- 新兴疗法针对线粒体来治疗心血管疾病.
结论:
- 了解心血管疾病中的线粒体机制对于开发新型诊断生物标志物和精确疗法至关重要.
- 准线粒体为改变心血管疾病管理带来了重大转化挑战和机遇.
- 弥合线粒体生物学和临床心脏病学对于未来的进步至关重要.
相关概念视频
Mitochondrial Membranes
16.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K
Coronary Artery Disease I: Introduction
869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
Mitochondria
19.5K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.5K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Cardiomyopathy II: Dilated Cardiomyopathy
457
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
457


